SK

Sonu Kumar

Active Director Designated Partner DIN 10083190
DIN 10083190 First appointment Mar 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sonu Kumar

Data last updated:

Sonu Kumar is a Designated Partner at Rgrowmed Pharmaceuticals Llp (since 2023). The company operates in Paper.

DIN 10083190
Primary Designation Designated Partner
Industry Paper
First Appointment 30 Mar 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner30 Mar 20232022Active

Board colleagues of Sonu Kumar

NameDINCompanyDesignation
Naeem10028406Rgrowmed Pharmaceuticals LlpDesignated Partner
Rahul Sharma10028407Rgrowmed Pharmaceuticals LlpDesignated Partner
Shanu Sharma10028408Rgrowmed Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Rgrowmed Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Sonu Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonu Kumar

Sonu Kumar currently holds 1 directorship: Rgrowmed Pharmaceuticals Llp (Designated Partner, since 30 Mar 2023).

Sonu Kumar was first appointed on 30 Mar 2023 as Designated Partner at Rgrowmed Pharmaceuticals Llp.

The current boards of Sonu Kumar's companies include Naeem (Rgrowmed Pharmaceuticals Llp), Rahul Sharma (Rgrowmed Pharmaceuticals Llp), Shanu Sharma (Rgrowmed Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available